To Get Help Now
Click Here
Today's Date:

New Jersey Levaquin Trial Begins

AddThis Social Bookmark Button

The lawsuits of Bob Beare and Paul Gaffney, filed against the makers of the antibiotic Levaquin, have been combined, as both are over age 60, from New Jersey, and allege they were not properly warned about the increased risk of side effects, namely the risk of tendon rupture, when using the medication.

Andres F. Alonso, of the firm Parker Waichman Alonso LLP, is lead plaintiff attorney in the mass tort litigation involving 1,763 New Jersey cases, in which the Beare/Gaffney case began this week.

Another 1,314 Levaquin tendon injury lawsuits have been consolidated in a federal multidistrict litigation in Minneapolis before U. S. District Court Judge John R. Tunheim.

In 2008, the Food & Drug Administration (FDA) required Levaquin and other antibiotics in the class known as fluoroquinolones, be revised to carry a Black Box warning about tendon injuries, which are more likely to occur in patients over the age of 60, and who are taking steroids, or have undergone heart, lung or kidney transplants.

The first test trial completed in December, 2010 ended with a verdict in favor of the plaintiff, and awarded $1.82 million. The second test trial ended in June, 2011 in favor of the defense.

The third test trial is scheduled to begin in November, 2011 in front of Judge Tunheim. disclaimer: This article: New Jersey Levaquin Trial Begins was posted on Thursday, September 1st, 2011 at 8:20 pm at and is filed under Defective Drug Lawsuits.

« »

Leave a Reply

You must be logged in to post a comment.